Amendment: Safety features for cicatrizants and fly larvae medicines

This procedure updates rules on how national authorities notify the Commission about medicinal products. It also clarifies which products, like those with cicatrizants or fly larvae, need to be included in the list of medicines that must have safety features.

This affects pharmaceutical companies and regulatory bodies. It ensures consistent application of safety feature requirements across the EU for specific medicinal products.